Revolution Medicines Inc (RVMD) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $0.75 million, and the earnings are expected to come in at -$0.87 per share. The full year 2024's revenue is expected to be $1.4 million and the earnings are expected to be -$3.33 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 6 Warning Signs with RVMD. Over the past 90 days, the revenue estimates for Revolution Medicines Inc ( NASDAQ:RVMD ) have seen a decrease, moving from $2.95 million to $1.4 million for the full year 2024, and from $2.80 billion to $2.80 billion for 2025. Similarly, earnings estimates have also been revised downwards from -$3.23 per share to -$3.33 per share for the full year 2024, and from -$3.73 per share to -$3.85 per share for 2025. In the previous quarter of December 31, 2023, Revolution Medicines Inc's ( NASDAQ:RVMD ) actual revenue was $0.74 million, which missed analysts' revenue expectations of $1.09 million by -31.99%. Revolution Medicines Inc's
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at HC Wainwright from $62.00 to $64.00. They now have a "buy" rating on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Needham & Company LLC from $61.00 to $68.00. They now have a "buy" rating on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at JPMorgan Chase & Co. from $54.00 to $63.00. They now have an "overweight" rating on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Piper Sandler from $57.00 to $70.00. They now have an "overweight" rating on the stock.MarketBeat
RVMD
Earnings
- 11/6/24 - Miss
RVMD
Sec Filings
- 11/19/24 - Form 4
- 11/15/24 - Form 144
- 11/15/24 - Form 4
- RVMD's page on the SEC website